Purple Biotech Ltd. Updates Company Presentation
Ticker: PPBT · Form: 6-K · Filed: Mar 18, 2025 · CIK: 1614744
Sentiment: neutral
Topics: company-update, investor-relations
TL;DR
Purple Biotech dropped a new investor deck on their site today.
AI Summary
On March 18, 2025, Purple Biotech Ltd. made available an updated Company Presentation on its website. This presentation is attached as Exhibit 99.1 to the 6-K filing.
Why It Matters
Investors can access the latest information about the company's strategy, pipeline, and financial health directly from this updated presentation.
Risk Assessment
Risk Level: low — This filing is an informational update and does not contain new financial or operational disclosures that would inherently increase risk.
Key Players & Entities
- Purple Biotech Ltd. (company) — Filer of the report
- March 18, 2025 (date) — Date the presentation was made available
- Exhibit 99.1 (document) — Attached company presentation
FAQ
What is the purpose of this 6-K filing?
The purpose of this 6-K filing is to report that Purple Biotech Ltd. has made available an updated Company Presentation on its website as of March 18, 2025.
Where can the updated Company Presentation be found?
The updated Company Presentation is attached to the 6-K filing as Exhibit 99.1 and can be viewed on the company's website.
What is the filing date of this report?
This report was filed on March 18, 2025.
What is the Commission File Number for Purple Biotech Ltd.?
The Commission File Number for Purple Biotech Ltd. is 001-37643.
What is the SIC code for Purple Biotech Ltd.?
The Standard Industrial Classification (SIC) code for Purple Biotech Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 18, 2025 regarding PURPLE BIOTECH LTD. (PPBT).